T/SZSMDA 012-2025 Active Group standards

T/SZSMDA 012-2025 High-risk hyperlipidemia management guideline

T/SZSMDA 012-2025 High-risk hyperlipidemia management guideline

Publish Date: 2025-06-20 Implement Date: 2025-07-01 For services related to genuine standard inquiry, procurement, translation, and other related services in China, please Contact Us
Price: $ 20.00
Out of stock

Basic Information

Standard Code: T/SZSMDA 012-2025
Standard Type: Group standards
Standard Status: Active
is_force_gb: no
CCS Name: -
ICS Name: Integrated medical science and healthcare devices
Publish Date: 2025-06-20
Implement Date: 2025-07-01

Scope

Main technical content: This document is applicable to the management of patients with high-risk hyperlipidemia, including those with elevated blood lipids accompanied by comorbidities, severe hyperlipidemia, hyperlipidemia during pregnancy, and familial hyperlipidemia, in outpatient and inpatient wards of all medical institutions in Shenzhen City, as well as in Shenzhen Health Management Centers and Community Health Centers. This document can be recommended as a reference for the diagnosis, treatment, and integrated management of high-risk hyperlipidemia in grassroots medical institutions at the county level and below across the country.

Development Information

Related Standards

Contact Us